Aspira Chemical competitorsClear all

Aspira Chemical's top competitors include Biogen, AbbVie, MyoKardia and Otonomy.
Aspira Chemical
Aspira Chemical
Aspira Chemical is a company specializing in bio products and chem products, pharma services, and technical resources.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
AbbVie
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Otonomy
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founding Date
Founding Date
2013
Founding Date
1978
Founding Date
2013
Founding Date
2012
Founding Date
2008
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Oakland, US HQ
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
São Paulo, BR
Mississauga, CA
see more
Locations
Lake Bluff, US HQ
Alger, DZ
Buenos Aires, AR
Mascot, AU
Wien, AT
Wavre, BE
Sarajevo, BA
see more
Locations
South San Francisco, US HQ
Brisbane, US
Locations
San Diego, US HQ
Employees
Employees
1
Employees
7,4005% decrease
Employees
30,000
Employees
23542% increase
Employees
49
Valuation ($)
Valuation ($)
N/A
Valuation ($)
45.5 b
Valuation ($)
170.6 b
Valuation ($)
4.3 b
Valuation ($)
129.6 m
Twitter followers
Twitter followers
N/A
Twitter followers
32.6 k
Twitter followers
63.7 k
Twitter followers
839
Twitter followers
228
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
42
Number of tweets (last 30 days)
53
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
40.6
Average likes per tweet (last 30 days)
15
Average likes per tweet (last 30 days)
6.1
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
86.79%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
221932
Alexa Website Rank
72819
Alexa Website Rank
411899
Alexa Website Rank
476422
Employee Rating
Employee Rating
N/A
Employee Rating
3.6
Employee Rating
3.8
Employee Rating
4.4
Employee Rating
4.3

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.4b (FY, 2019)
Revenue (est.)
$33.3b (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$600k (FY, 2019)
Cost of goods
Cost of goods
N/A
Cost of goods
$2b (FY, 2019)
Cost of goods
$7.4b (FY, 2019)
Cost of goods
N/A
Cost of goods
$912k (FY, 2019)
Gross profit
Gross profit
N/A
Gross profit
$12.4b (FY, 2019)
Gross profit
$25.8b (FY, 2019)
Gross profit
N/A
Gross profit
($312k) (FY, 2019)
Net income
Net income
N/A
Net income
$5.9b (FY, 2019)
Net income
$7.9b (FY, 2019)
Net income
($276.2m) (FY, 2019)
Net income
($44.7m) (FY, 2019)

Operating

Patents (US)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Patents (US)
N/A
Patents (US)
2 (FY, 2018)
Patents (US)
N/A
Patents Issued
Patents Issued
N/A
Patents Issued
34 (FY, 2019)
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
88 (FY, 2016)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
9 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
1 (FY, 2018)
Phase I Trials Products
1 (FY, 2016)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
11 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
2 (FY, 2018)
Phase II Trials Products
2 (FY, 2016)
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2018)
Phase III Trials Products
2 (FY, 2016)
Pre-Clinical Phase Products
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
N/A
Pre-Clinical Phase Products
3 (FY, 2018)
Pre-Clinical Phase Products
1 (FY, 2016)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 98m
Total funding raised
$ 153.4m
For sources of this data, please see the company profile

View company profiles

Biogen
HQ
Cambridge, US
Employees
7,400↓ 5% decrease

Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.

View company
AbbVie
HQ
Lake Bluff, US
Employees
30,000

AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company
Otonomy
HQ
San Diego, US
Employees
49

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.

View company